Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goudsmit

Showing results (141-150 of 424) with videos related to

Pageof 43
Sort By:
Vox Sanguinis|January 1, 1986
Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacsJ Goudsmit, F Miedema, C Breederveld, et al.
AIDS (London, England)|February 1, 1988
Diagnostic value of specific IgM antibodies in primary HIV infectionJ M Lange, J V Parry, F de Wolf, et al.
The Journal of General Virology|October 1, 1991
Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1J P Langedijk, N K Back, P J Durda, et al.
International Journal of STD & AIDS|July 1, 1990
Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcomaR de Wit, P J Bakker, S A Danner, et al.
The Journal of General Virology|April 24, 2004
Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivoS Mercier, S Verhaagh, J Goudsmit, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 1988
[The AIDS-dementia complex: primary infection by human immunodeficiency virus type I]J de Gans, P Portegies, M M Derix, et al.
AIDS Research and Human Retroviruses|October 1, 1994
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I TaxK F Copeland, A G Haaksma, J Goudsmit, et al.
Journal of Virology|November 1, 1993
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodiesN K Back, L Smit, M Schutten, et al.
AIDS Research and Human Retroviruses|October 9, 1998
Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, BelarusV V Lukashov, E V Karamov, V F Eremin, et al.
Acta Neurologica Scandinavica|April 1, 1987
Serum antibodies to HTLV-I in human demyelinating diseaseL Epstein, B Blumberg, J Crowley, et al.
Pageof 43

Showing results (141-150 of 424) with videos related to

Sort By:
Pageof 43
Vox Sanguinis|January 1, 1986
Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacsJ Goudsmit, F Miedema, C Breederveld, et al.
AIDS (London, England)|February 1, 1988
Diagnostic value of specific IgM antibodies in primary HIV infectionJ M Lange, J V Parry, F de Wolf, et al.
The Journal of General Virology|October 1, 1991
Neutralizing activity of anti-peptide antibodies against the principal neutralization domain of human immunodeficiency virus type 1J P Langedijk, N K Back, P J Durda, et al.
International Journal of STD & AIDS|July 1, 1990
Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcomaR de Wit, P J Bakker, S A Danner, et al.
The Journal of General Virology|April 24, 2004
Adenovirus fibre exchange alters cell tropism in vitro but not transgene-specific T CD8+ immune responses in vivoS Mercier, S Verhaagh, J Goudsmit, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 20, 1988
[The AIDS-dementia complex: primary infection by human immunodeficiency virus type I]J de Gans, P Portegies, M M Derix, et al.
AIDS Research and Human Retroviruses|October 1, 1994
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I TaxK F Copeland, A G Haaksma, J Goudsmit, et al.
Journal of Virology|November 1, 1993
Mutations in human immunodeficiency virus type 1 gp41 affect sensitivity to neutralization by gp120 antibodiesN K Back, L Smit, M Schutten, et al.
AIDS Research and Human Retroviruses|October 9, 1998
Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, BelarusV V Lukashov, E V Karamov, V F Eremin, et al.
Acta Neurologica Scandinavica|April 1, 1987
Serum antibodies to HTLV-I in human demyelinating diseaseL Epstein, B Blumberg, J Crowley, et al.
Pageof 43